March 27, 2007
|
March 20, 2007
|
March 16, 2007
|
March 13, 2007
|
March 09, 2007
 |
Study Finds Viread Advantages in Black Patients
An analysis of two Gilead-sponsored studies suggests that black HIV-positive patients have a better chances of an undetectable viral load after 96 weeks using treatment regimens containing Viread compared to those containing the thymidine analogues Retrovir or Zerit.
|
 |
|
March 07, 2007
|
March 05, 2007
|
March 02, 2007
|
March 01, 2007
|
|
|